Seres Therapeutics, Inc. (MCRB)

Seres Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	106	181	698	765	2,236	241
Market Cap Growth	-83.65%	-74.06%	-8.81%	-65.78%	825.79%	30.76%
Enterprise Value	201	259	671	516	2,023	191
PE Ratio	-	-1.59	-2.79	-11.67	-25.08	-3.44
PS Ratio	0.84	1.43	97.88	5.28	67.31	7.00
PB Ratio	-1.96	-4.03	64.71	5.82	12.79	-5.00
P/FCF Ratio	-1.46	-1.44	-2.92	-265.84	-23.73	-3.11
P/OCF Ratio	-1.54	-1.54	-3.05	114.40	-23.88	-3.16
EV/Sales Ratio	1.58	2.05	94.10	3.56	60.90	5.55
EV/EBITDA Ratio	-4.13	-3.03	-2.89	-9.65	-26.16	-3.19
EV/EBIT Ratio	-3.17	-2.57	-2.75	-8.23	-23.46	-2.74
EV/FCF Ratio	-2.64	-2.06	-2.81	-179.15	-21.47	-2.47
Debt / Equity Ratio	-3.59	-4.77	15.08	0.37	0.23	-0.93
Debt / EBITDA Ratio	-4.18	-2.50	-0.70	-0.92	-0.53	-0.75
Debt / FCF Ratio	-2.68	-1.71	-0.68	-17.10	-0.43	-0.58
Quick Ratio	1.29	1.47	2.21	3.63	5.67	2.10
Current Ratio	1.68	1.78	2.28	3.69	5.79	2.18
Asset Turnover	0.34	0.36	0.02	0.44	0.15	0.27
Interest Coverage	-4.20	-7.63	-40.55	-21.54	-29.48	-139.00
Return on Equity (ROE)	340.60%	533.70%	-548.60%	-47.50%	-151.30%	167.00%
Return on Assets (ROA)	-22.40%	-32.40%	-79.80%	-19.80%	-39.20%	-55.20%
Return on Capital (ROIC)	-49.86%	-63.87%	-142.17%	-35.69%	-40.89%	2028.10%
Earnings Yield	-77.88%	-62.84%	-35.85%	-8.57%	-3.99%	-29.10%
FCF Yield	-75.33%	-69.26%	-34.20%	-0.38%	-4.21%	-32.10%
Buyback Yield / Dilution	-16.08%	-18.44%	-17.86%	-14.93%	-40.85%	-39.04%
Total Shareholder Return	-16.08%	-18.44%	-17.86%	-14.93%	-40.85%	-39.04%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).